Human liver model market: Qualitative Analysis, Quantitative Analysis, Forecast up to 2030

SDKI Inc. published a new research report on "Human Liver Model Market-Global Forecast 2022". The report provides a complete assessment of the market and its growth prospects, along with new business opportunities in the industry. It also includes market size and annual growth during the 2017-2022 forecast period.

Report sample URL
https://www.sdki.jp/sample-request-109702

The global human liver model market is estimated to reach US $ 2.56 billion by 2022 from US $ 1.35 billion in 2017 and is expected to grow at a CAGR of 13.6%. Increasing attention to the development of alternatives to animal testing models, a significant increase in research funding and venture capital investment for the development of liver models, and the growth of initiatives to raise awareness about liver organoids are the growth of the market. There are several factors that drive. In addition, the need for early detection of drug toxicity to minimize increased research activity on liver organoids, increased prevalence of non-alcoholic fatty liver disease, and economic loss due to late-stage drug failure. The increase is expected to promote the growth of the human liver model.

However, issues related to the incorporation of organoids into existing workflows are expected to curb the growth of this market.

Report sample URL
https://www.sdki.jp/sample-request-109702

Market Segments
The human liver model market is divided by drug discovery platform (non-alcoholic fatty liver organoids, liver-on-chip, 2D models, animal models, 3D bioprinting) and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Based on the drug discovery platform, the liver-on-chip segment is expected to grow at the highest rate during the forecast period.

Based on the drug discovery platform, the market will be divided into liver organoids, liver-on-chip, 2D models, animal models, and 3D bioprinting. The liver-on-chip segment is expected to grow at a maximum CAGR during the forecast period. This may be due to the simplicity of this model and the ability of on-chip liver tissue to maintain metabolic activity and phenotype similar to the in vivo environment. In addition, the majority of major players, research institutes, government and non-governmental organizations are raising funds for the development of innovative liver-based models. In addition, the major companies operating in this market have begun partnerships and collaborations with pharmaceutical companies to strengthen their position in the market. This strategy allows market players to assess the performance of liver products on chips in drug development and other pharmaceutical research processes.

Regional Overview
In addition, the report covers all regions of the world, divided into North America, Europe, Asia Pacific, Latin America, Middle East & Africa and more. The North American region is expected to achieve the highest growth between 2017-2022 due to the established pharmaceutical and biotechnology industry and increased government spending. In addition, expanding initiatives to raise awareness about organoids and increasing the incidence of NAFLD are expected to boost the market.

Details of the survey report
https://www.sdki.jp/reports/human-liver-models-market/109702

For more detailed analysis, each region is further divided into countries:
Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, and other Asia Pacific)
North America (US and Canada)
Middle East and Africa (Israel, GCC [Saudi Arabia, United Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa)
Latin America (Brazil, Mexico, Argentina, and other Latin America)
Europe (UK, Germany, France, Italy, Spain, Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia and other Europe).

Key Players:

In the Human Liver Model Market include Emulate (US), Ascendance Bio (US), HμREL (US), CN Bio (UK), Organovo (US), Cyfuse Biomedical (Japan). )And so on. The study includes a detailed competitive analysis of these major companies in the human liver model market, corporate profiles, recent developments, and key market strategies.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.